Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. (Q54267061)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. |
scientific article |
Statements
Definitive chemoradiotherapy with low-dose continuous 5-fluorouracil reduces hematological toxicity without compromising survival in esophageal squamous cell carcinoma patients. (English)
1 reference
Hirotake Saito
1 reference
Atsushi Ohta
1 reference
Eisuke Abe
1 reference
Motoki Kaidu
1 reference
Miki Shioi
1 reference
Toshimichi Nakano
1 reference
Tomoya Oshikane
1 reference
Kensuke Tanaka
1 reference
Katsuya Maruyama
1 reference
Naotaka Kushima
1 reference
Satoshi Tanabe
1 reference
Satoru Utsunomiya
1 reference
Ryuta Sasamoto
1 reference
Hidefumi Aoyama
1 reference
24 December 2017
1 reference
9
1 reference
12-17
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference